azathioprine has been researched along with Neuromuscular Junction Diseases in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Neuromuscular Junction Diseases: Conditions characterized by impaired transmission of impulses at the NEUROMUSCULAR JUNCTION. This may result from disorders that affect receptor function, pre- or postsynaptic membrane function, or ACETYLCHOLINESTERASE activity. The majority of diseases in this category are associated with autoimmune, toxic, or inherited conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Skeie, GO | 1 |
| Apostolski, S | 1 |
| Evoli, A | 1 |
| Gilhus, NE | 1 |
| Hart, IK | 1 |
| Harms, L | 1 |
| Hilton-Jones, D | 1 |
| Melms, A | 1 |
| Verschuuren, J | 1 |
| Horge, HW | 1 |
1 other study available for azathioprine and Neuromuscular Junction Diseases
| Article | Year |
|---|---|
Guidelines for the treatment of autoimmune neuromuscular transmission disorders.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases of the Nervous System; Azathioprine; Humans; Immunosupp | 2006 |